On May 30, 2025, the Board of Directors of the Competition Authority, in the exercise of the powers conferred upon it by paragraph d) of paragraph 1 of article 19 of the Statutes, approved by Decree-Law no. 125/2014, of 18 August, decides to adopt a decision of non-opposition to the concentration operation, under the terms of paragraph b) of number 1 of article 50 of the Competition Law, since it is not susceptible to create significant impediments to effective competition in the national market or in a substantial part of it.

Portuguese Competition Authority Approves Merger Between Luz Saúde and C2 Capital Partners

On May 30, 2025, the Board of Directors of the Portuguese competition authority, known as AdC, made a significant decision regarding the merger identified as 91/2024, involving Luz Saúde and C2 Capital Partners alongside Infrapetagi and HL.

 The AdC's decision was based on the assessment that the merger would not create significant impediments to effective competition within the national market or in a substantial part of it. This conclusion was reached under the provisions of the Competition Law, specifically referencing article 50.

 The approval reflects the authority's commitment to maintaining a competitive market environment while allowing for necessary consolidations that do not adversely affect market dynamics.



The AdC issued a non-opposition decision to the merger 91/2024 - Luz Saúde*C2 Capital Partners/Infrapetagi*HL.
The AdC issued a non-opposition decision to the merger 91/2024 - Luz Saúde*C2 Capital Partners/Infrapetagi*HL.

Portuguese Competition Authority Approves Merger Between Luz Saúde and C2 Capital Partners

The Portuguese competition authority has approved the merger between Luz Saúde and C2 Capital Partners, determining it will not hinder competition in the market.